Chase Knickerbocker Score: 29
Analyst at
Craig-Hallum
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+42.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
52%
13 W / 12 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
58%
11 W / 8 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
5%
1 W / 18 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 19 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
54%
13 W / 11 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
54%
13 W / 11 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 04, 2026 |
Celcuity Inc
CELC
|
BUY |
$189.00
Est. +29%
|
$146.24 | $151.02 |
Pending
|
$107.95
-26.2%
|
| Jan 09, 2026 |
Indivior Plc - ADR
INVVY
|
BUY |
$50.00
Est. +129%
|
$21.85 | - | - |
$21.85
0.0%
|
| Oct 31, 2025 |
Phathom Pharmaceuticals Inc
PHAT
|
BUY |
$22.00
Est. +60%
|
$13.76 | $18.31 |
Pending
|
$11.20
-18.6%
|
| Oct 21, 2025 |
Delcath Systems Inc
DCTH
|
BUY |
$20.00
Est. +75%
|
$11.42 | $13.21 |
Pending
|
$13.20
+15.6%
|
| Sep 23, 2025 |
Harrow Inc
HROW
|
BUY |
$64.00
Est. +31%
|
$48.93 | $54.85 |
Pending
|
$42.74
-12.7%
|
| Aug 27, 2025 |
Indivior Plc
INDV
|
BUY |
$34.00
Est. +39%
|
$24.51 | $42.81 |
Target Met
|
$39.80
+62.4%
|
| Aug 15, 2025 |
Fennec Pharmaceuticals Inc
FENC
|
BUY |
$14.00
Est. +64%
|
$8.54 | $11.29 |
Pending
|
$10.70
+25.3%
|
| Jun 16, 2025 |
Neuraxis Inc
NRXS
|
BUY |
$7.00
Est. +178%
|
$2.52 | $9.33 |
Target Met
|
$7.06
+180.2%
|
| May 07, 2025 |
Bioventus Inc - Ordinary Shares - Class A
BVS
|
BUY |
$15.00
Est. +142%
|
$6.20 | $11.25 |
Miss
|
$10.48
+69.0%
|
| Nov 04, 2024 |
Polypid Ltd
PYPD
|
BUY |
$10.00
Est. +200%
|
$3.33 | $3.93 |
Miss
|
$5.02
+50.8%
|
| Oct 28, 2024 |
Eton Pharmaceuticals Inc
ETON
|
BUY |
$15.00
Est. +78%
|
$8.44 | $23.00 |
Target Met
|
$37.50
+344.3%
|
| Oct 18, 2024 |
Xtant Medical Holdings Inc
XTNT
|
BUY |
$1.50
Est. +168%
|
$0.56 | $0.84 |
Miss
|
$0.41
-26.3%
|
| Sep 23, 2024 |
Indivior Plc
INDV
|
BUY |
$20.00
Est. +118%
|
$9.16 | $25.10 |
Target Met
|
$39.80
+334.5%
|
| Aug 09, 2024 |
Harrow Inc
HROW
|
BUY |
$45.00
Est. +28%
|
$35.25 | $59.23 |
Target Met
|
$42.74
+21.2%
|
| Aug 07, 2024 |
Bioventus Inc - Ordinary Shares - Class A
BVS
|
BUY |
$12.00
Est. +45%
|
$8.25 | $14.37 |
Target Met
|
$10.48
+27.0%
|
| Jul 31, 2024 |
Myomo Inc
MYO
|
BUY |
$7.00
Est. +58%
|
$4.44 | $7.17 |
Precision Hit (±3%)
|
$1.03
-76.8%
|
| Jul 10, 2024 |
Indivior Plc
INDV
|
BUY |
$24.00
Est. +136%
|
$10.19 | $15.88 |
Miss
|
$39.80
+290.6%
|
| Jun 24, 2024 |
Alimera Sciences Inc.
ALIM
|
SELL |
$5.50
Est. +1%
|
$5.54 | $4.32 (Low) |
Target Met
|
$5.54
0.0%
|
| Jun 21, 2024 |
Harrow Inc
HROW
|
BUY |
$30.00
Est. +51%
|
$19.93 | $59.23 |
Target Met
|
$42.74
+114.5%
|
| May 15, 2024 |
Fennec Pharmaceuticals Inc
FENC
|
BUY |
$17.00
Est. +132%
|
$7.34 | $7.06 |
Miss
|
$10.70
+45.8%
|
| May 06, 2024 |
Eton Pharmaceuticals Inc
ETON
|
BUY |
$8.00
Est. +116%
|
$3.71 | $18.41 |
Target Met
|
$37.50
+910.8%
|
| May 01, 2024 |
CVRx Inc
CVRX
|
BUY |
$23.00
Est. +148%
|
$9.27 | $18.50 |
Miss
|
$5.60
-39.6%
|
| Apr 24, 2024 |
Guardant Health Inc
GH
|
BUY |
$28.00
Est. +56%
|
$17.94 | $50.89 |
Target Met
|
$167.98
+836.3%
|
| Apr 03, 2024 |
Indivior Plc
INDV
|
BUY |
$37.00
Est. +73%
|
$21.43 | $15.50 |
Miss
|
$39.80
+85.7%
|
| Mar 19, 2024 |
Fennec Pharmaceuticals Inc
FENC
|
BUY |
$18.00
Est. +63%
|
$11.01 | $7.06 |
Miss
|
$10.70
-2.8%
|
Celcuity Inc
CELC
May 04, 2026
Signal & Target
BUY
$189.00
Start Price
$146.24
Best Price (1Y)
$151.02
Current Price
$107.95
Return
-26.2%
Indivior Plc - ADR
INVVY
Jan 09, 2026
Signal & Target
BUY
$50.00
Start Price
$21.85
Best Price (1Y)
-
Current Price
$21.85
Return
0.0%
Phathom Pharmaceuticals Inc
PHAT
Oct 31, 2025
Signal & Target
BUY
$22.00
Start Price
$13.76
Best Price (1Y)
$18.31
Current Price
$11.20
Return
-18.6%
Delcath Systems Inc
DCTH
Oct 21, 2025
Signal & Target
BUY
$20.00
Start Price
$11.42
Best Price (1Y)
$13.21
Current Price
$13.20
Return
+15.6%
Harrow Inc
HROW
Sep 23, 2025
Signal & Target
BUY
$64.00
Start Price
$48.93
Best Price (1Y)
$54.85
Current Price
$42.74
Return
-12.7%
Indivior Plc
INDV
Aug 27, 2025
Signal & Target
BUY
$34.00
Start Price
$24.51
Best Price (1Y)
$42.81
Current Price
$39.80
Return
+62.4%
Fennec Pharmaceuticals Inc
FENC
Aug 15, 2025
Signal & Target
BUY
$14.00
Start Price
$8.54
Best Price (1Y)
$11.29
Current Price
$10.70
Return
+25.3%
Neuraxis Inc
NRXS
Jun 16, 2025
Signal & Target
BUY
$7.00
Start Price
$2.52
Best Price (1Y)
$9.33
Current Price
$7.06
Return
+180.2%
Bioventus Inc - Ordinary Shares - Class A
BVS
May 07, 2025
Signal & Target
BUY
$15.00
Start Price
$6.20
Best Price (1Y)
$11.25
Current Price
$10.48
Return
+69.0%
Polypid Ltd
PYPD
Nov 04, 2024
Signal & Target
BUY
$10.00
Start Price
$3.33
Best Price (1Y)
$3.93
Current Price
$5.02
Return
+50.8%
Eton Pharmaceuticals Inc
ETON
Oct 28, 2024
Signal & Target
BUY
$15.00
Start Price
$8.44
Best Price (1Y)
$23.00
Current Price
$37.50
Return
+344.3%
Xtant Medical Holdings Inc
XTNT
Oct 18, 2024
Signal & Target
BUY
$1.50
Start Price
$0.56
Best Price (1Y)
$0.84
Current Price
$0.41
Return
-26.3%
Indivior Plc
INDV
Sep 23, 2024
Signal & Target
BUY
$20.00
Start Price
$9.16
Best Price (1Y)
$25.10
Current Price
$39.80
Return
+334.5%
Harrow Inc
HROW
Aug 09, 2024
Signal & Target
BUY
$45.00
Start Price
$35.25
Best Price (1Y)
$59.23
Current Price
$42.74
Return
+21.2%
Bioventus Inc - Ordinary Shares - Class A
BVS
Aug 07, 2024
Signal & Target
BUY
$12.00
Start Price
$8.25
Best Price (1Y)
$14.37
Current Price
$10.48
Return
+27.0%
Myomo Inc
MYO
Jul 31, 2024
Signal & Target
BUY
$7.00
Start Price
$4.44
Best Price (1Y)
$7.17
Current Price
$1.03
Return
-76.8%
Indivior Plc
INDV
Jul 10, 2024
Signal & Target
BUY
$24.00
Start Price
$10.19
Best Price (1Y)
$15.88
Current Price
$39.80
Return
+290.6%
Alimera Sciences Inc.
ALIM
Jun 24, 2024
Signal & Target
SELL
$5.50
Start Price
$5.54
Best Price (1Y)
$4.32
Current Price
$5.54
Return
0.0%
Harrow Inc
HROW
Jun 21, 2024
Signal & Target
BUY
$30.00
Start Price
$19.93
Best Price (1Y)
$59.23
Current Price
$42.74
Return
+114.5%
Fennec Pharmaceuticals Inc
FENC
May 15, 2024
Signal & Target
BUY
$17.00
Start Price
$7.34
Best Price (1Y)
$7.06
Current Price
$10.70
Return
+45.8%
Eton Pharmaceuticals Inc
ETON
May 06, 2024
Signal & Target
BUY
$8.00
Start Price
$3.71
Best Price (1Y)
$18.41
Current Price
$37.50
Return
+910.8%
CVRx Inc
CVRX
May 01, 2024
Signal & Target
BUY
$23.00
Start Price
$9.27
Best Price (1Y)
$18.50
Current Price
$5.60
Return
-39.6%
Guardant Health Inc
GH
Apr 24, 2024
Signal & Target
BUY
$28.00
Start Price
$17.94
Best Price (1Y)
$50.89
Current Price
$167.98
Return
+836.3%
Indivior Plc
INDV
Apr 03, 2024
Signal & Target
BUY
$37.00
Start Price
$21.43
Best Price (1Y)
$15.50
Current Price
$39.80
Return
+85.7%
Fennec Pharmaceuticals Inc
FENC
Mar 19, 2024
Signal & Target
BUY
$18.00
Start Price
$11.01
Best Price (1Y)
$7.06
Current Price
$10.70
Return
-2.8%